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Abstract
This White Paper highlights the developmental period as a plastic phase, which allows the organism to adapt to
changes in the environment to maintain or improve reproductive capability in part through sustained health.
Plasticity is more prominent prenatally and during early postnatal life, i.e., during the time of cell differentiation and
specific tissue formation. These developmental periods are highly sensitive to environmental factors, such as
nutrients, environmental chemicals, drugs, infections and other stressors. Nutrient and toxicant effects share many
of the same characteristics and reflect two sides of the same coin. In both cases, alterations in physiological
functions can be induced and may lead to the development of non-communicable conditions. Many of the major
diseases – and dysfunctions – that have increased substantially in prevalence over the last 40 years seem to be
related in part to developmental factors associated with either nutritional imbalance or exposures to environmental
chemicals. The Developmental Origins of Health and Disease (DOHaD) concept provides significant insight into new
strategies for research and disease prevention and is sufficiently robust and repeatable across species, including
humans, to require a policy and public health response. This White Paper therefore concludes that, as early
development (in utero and during the first years of postnatal life) is particularly sensitive to developmental
disruption by nutritional factors or environmental chemical exposures, with potentially adverse consequences for
health later in life, both research and disease prevention strategies should focus more on these vulnerable life
stages.
Keywords: Environmental exposure, Fetal development, Non-communicable disease, Nutritional requirements,
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Background
For many years biologists considered the developmental
period to be controlled by a strict, hard-wired genetic
program, and thus it was uncertain how it could be
influenced by the environment. It is now clear that de-
velopment is plastic, and that it allows the organism to
respond to the surrounding environment, especially dur-
ing early development when cells are differentiating and
tissues are developing. This capacity is based on molecu-
lar pathways that lead to control of gene expression and
induction of specific phenotypes in the absence of DNA
sequence modification [1]. These pathways, as currently
understood, include DNA methylation, histone covalent
modification, and noncoding RNA expression. Such epi-
genetic modifications can be passed from one cell gener-
ation to the next and, in some cases, when germ cells
are targeted, can be transgenerationally transmitted [2].
Furthermore, these changes can be cell, tissue, and sex
specific, and time dependent. In many cases they may
not be apparent during a latent period which may last
from months to years or decades. Thus, each individual
has one genome, but will hold multiple epigenomes.
The ability to respond to environmental conditions can
be evolutionarily advantageous by allowing fine-tuning of
gene expression, likely through epigenetic mechanisms
[3]. Thus, developmentally plastic processes allow the or-
ganism to adapt to changing environments in order to
maintain or improve reproductive capability in part by
sustaining health through the reproductive period.
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adaptive processes may also have adverse consequences
on some functions and disease risks later in life. Further-
more, these mechanisms are also sensitive to environ-
mental stimuli other than the nutrients and physiological
factors that are normative, in evolutionary terms, to the
human environment. Indeed, drugs, industrial chemicals,
tobacco smoke, and other environmental exposures can
affect these same mechanisms leading to adverse conse-
quences such as increased disease risk [4].
The sensitivity of the epigenetic system to environ-
mental factors occurs primarily during the period of de-
velopmental plasticity because this is the time when
epigenetic marks undergo critical modifications [5].
Once a tissue or system is fully developed, while still
somewhat plastic, it is less sensitive to alterations by en-
vironmental stimuli. The most sensitive window for epi-
genetic effects is different for each tissue and may
extend into early childhood and perhaps into puberty or
beyond for some tissues such as the brain and the repro-
ductive system [4,6]. There are also sex differences in
the effects on gene expression and disease risk. Clearly,
epigenetic alterations provide remarkable molecular can-
didate mechanisms even for subtle developmental tox-
icity to cause delayed effects. However, such
mechanisms still need further experimental exploration.
Since nutritional imbalance (over- or under-nutrition)
or environmental chemical (toxicant) exposures during
development can each increase disease risk, their effects
are likely to share some common pathways. Indeed, hor-
mones, cytokines and nutritional components can both
directly activate receptors that stimulate gene expression
and also activate or inhibit the enzymes and pathways
that are responsible for DNA methylation, chromatin re-
modelling and non-coding RNAs which ultimately con-
trol gene expression. Thus, epigenetic regulatory
pathways are likely sites for effects of both nutrient and
environmental toxicant effects during development and
potentially also across the lifespan.
In this White Paper, we highlight key features of this
paradigm and indicate research and policy changes
needed to develop a stronger focus on prevention of
non-communicable conditions. A draft was developed
for discussion at the PPTOX III conference on Environ-
mental Stressors in the Developmental Origins of Dis-
ease: Evidence and Mechanisms, held in Paris, France on
14–16 May, 2012. This revised version takes into ac-
count written comments submitted by conference parti-
cipants. In the spirit of the Faroes Statement [7], this
White Paper aims at providing an updated overview to
outline the new research challenges and the possible
implications for public health. However, it cannot pro-
vide an extensive list of references from this burgeoning
field and refers only to selected review articles [1-6,8].
The conditions that are affected by nutritional or en-
vironmental chemical exposures during development in-
clude the pathophysiologies, diseases, and syndromes
that constitute major public health problems across the
globe: obesity, diabetes, hypertension, cardiovascular dis-
ease, asthma and allergy, immune and autoimmune dis-
eases, neurodevelopmental and neurodegenerative
diseases, precocious puberty, infertility, some cancer
types, osteoporosis, depression, schizophrenia and
sarcopenia.
The risk of many non-communicable diseases is
set during development
Advances in our understanding of molecular epigenetics
have added considerable insight into the effects of envir-
onmental stimuli during development and the signifi-
cance of the timing of exposures to these stimuli on
later human health. It provides mechanisms for observa-
tions that were initially descriptive. All complex diseases
have an environmental component, and a shrinking frac-
tion is attributed solely to fixed genetic variation. This
conclusion is based on the substantial increase in inci-
dence of many non-communicable conditions during
the last 20–40 years, a time interval much too short to
be attributable to genetic change. The scientific focus
has therefore turned to gene-environment interactions
as a dominating contributor to disease susceptibility and
pathogenesis. To prevent such disease or dysfunction,
the interaction of genetic and environmental compo-
nents must be explored across the lifespan, though with
a new and strengthened focus on early development.
For the purposes of this White Paper, “environment”
comprises nutrition, infections, the microbiome, drugs,
man-made environmental chemicals, and other exogen-
ous stresses. Some exposures are largely novel (in evolu-
tionary terms) and anthropogenic, and so their effects,
and the physiological responses to them, have not been
subject to selection pressure. In contrast, the human
body has evolved mechanisms of developmental plasti-
city and homeostasis to cope with changes in nutrition,
stress, infections and the microbiome as commonly
encountered modifiers and stressors. Whether the re-
sultant change in phenotype from this latter group is
adaptive (i.e., might confer a fitness advantage) depends
on the nature and strength of the stimuli during devel-
opment and whether they convey useful information
about the external environment later in life. If there is a
match between the adaptive change and the subsequent
lifetime environment then the change is likely to be
beneficial to adult health. If there is a mismatch between
the adaptive change and the subsequent lifetime envir-
onment then the response will likely be in fact maladap-
tive and lead to dysfunction and greater risk of disease.
However, it is important to note that changes can be
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others, as in the case of energy storage as fat during de-
velopment which is beneficial and pathological obesity
in adulthood. Other components of the life-course strat-
egy interact, as in the trade-off between defence and re-
pair processes up to the time of reproduction, with a
decline during aging. It is important in this context to
note the marked increase in lifespan in recent decades
which exposes situations where natural selection has
been weak or absent.
Disruption of normal signalling pathways during de-
velopment occurs if the challenge is very strong or evo-
lutionarily novel. It can result in gross effects, such as
death, birth defects, and low birth weight. However,
more commonly, the functional changes are subtle, at
least initially. Thus, developmental exposures to envir-
onmental chemicals at low doses, especially endocrine
disrupting chemicals (EDCs), can result in functional
changes in gene expression, and whilst they do not lead
to any phenotype change observable at birth they none-
theless may lead to increased risk of dysfunction and
disease later in life. In contrast, exposure to environ-
mental chemicals in adults typically results in acute
effects that persist only as long as the environmental
chemical is present. Still, other sensitive windows may
occur, e.g., during pregnancy, pre-puberty and aging, so
caution is required when interpreting results from ex-
posure paradigms beyond early development.
Although the term disruption is widely used in the
context of EDCs and is retained here, its use in regard
to environmentally-induced developmental changes in
general implies that normal developmental processes
may not always be disrupted. Thus, nutritional signals,
EDCs and other agents can act on endogenous receptors
(e.g., steroid hormone receptors), and thereby affect nor-
mal control processes, although not necessarily inducing
a pathological state.
Nutritional imbalance during development can
increase risk for disease later in life
The underlying causes of fetal under-nutrition world-
wide include: poor or unbalanced maternal nutrition;
suboptimal body composition; excessive physical work-
load before and during pregnancy; and poor function of
the fetal supply line (e.g., placental dysfunction). Mater-
nal under-nutrition remains a major problem in low-
and middle-income countries. Inadequate and poor
quality diets are more common among women of low
income and low educational attainment, in addition to
those who are food insecure. While current evidence of
fetal influences on later health has been mainly linked to
maternal diet, emerging evidence points to the import-
ant role of maternal obesity, excessive weight gain in
pregnancy, and gestational diabetes as factors that influ-
ence disease risks in the next generation.
Evidence for the effects of maternal malnutrition on
offspring comes from a historical cohort of Dutch indivi-
duals whose mothers were exposed during the wartime
famine of 1944–1945. Offspring of women exposed dur-
ing early pregnancy were more likely to develop the
metabolic syndrome in adulthood compared to offspring
of women pregnant before or after the famine. The
effects were dependent on the trimester of gestation in
which famine was experienced. Epigenetic analyses in
these individuals nearly 60 years later show differential
methylation in several genes involved in growth and
metabolic control, which are dependent on sex and time
of exposure during gestation. Hypomethylation at the
promoter of IGF2, a maternally imprinted gene impli-
cated in growth and development, has also been
observed in those exposed during the peri-conceptional
period relative to unexposed siblings, although the effect
is small. In other more recently established cohorts,
individuals exposed in utero and infancy to the Nigerian
civil war famine of 1968–70 were at increased risk of
hypertension, impaired glucose tolerance and being
overweight about 40 years later. Similarly, women
exposed to the 1959–61 famine in China during gesta-
tion or early childhood are reported to have a greater
risk of metabolic syndrome.
Recent studies have shown that even subtle imbalances
in maternal nutrition are associated with the epigenetic
profile at birth, which in turn is linked to markers of
metabolic risk. Maternal carbohydrate consumption dur-
ing the first trimester of pregnancy is inversely corre-
lated with methylation levels at a single CpG in the
RXRA gene in umbilical cord tissue and, in turn, is asso-
ciated with child’s adiposity at age 6 or 9 years of age.
The early epidemiological data showed that the rela-
tion between birth weight and later disease risk is U-
shaped; high birth weight also is associated with greater
disease risk. This effect, although small in historical
cohorts such as the Hertfordshire study, is very pro-
nounced in populations such as the Pima who have a
high prevalence of metabolic disease. There is now in-
creasing epidemiological evidence that fetal overnutri-
tion – as judged from indicators such as maternal
obesity, excessive gestational weight gain, and gestational
diabetes (GDM) – can produce a similar offspring
phenotype to that of undernutrition. For example, ma-
ternal body mass index (BMI) has been positively corre-
lated with total and abdominal adiposity, and with
hepatic lipid content in infancy, across the entire range
of maternal BMI. Exposure to a diabetic intrauterine mi-
lieu is a main risk factor for type 2 diabetes and is also
associated with greater adiposity from infancy. Preg-
nancy weight gain that exceeds the medical guidelines is
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obesity. The epigenetic basis for these effects is now
being explored.
The dramatic increases in rates of overweight, obesity,
and GDM in pregnant women during the past decade
may have serious long-term consequences for public
health. In many western countries, close to half of all ex-
pectant mothers are now overweight, and the prevalence
of GDM in some Asian countries has increased to 20%.
In Canadian First Nation populations, GDM may explain
up to 30% of the highly increased incidence of type 2
diabetes in the next generation. These trends are gener-
ating a vicious trans-generational cycle of ‘diabesity’.
Exposures to environmental chemicals during
development can increase disease risk later in life
While congenital malformations were long thought to
be mediated by fixed genetic mutations, the phocomelia
caused by thalidomide changed the perception that
human development is autonomous. Fetal alcohol syn-
drome and the impact of congenital rubella infection
further added to the evidence that stressors could result
in lasting adverse effects. In all of these cases, the expos-
ure occurred via the pregnant mother, who was herself
barely affected, and only during a short period of time.
Thus, exposures that had virtually no detrimental effect
on the mature organism caused very serious adverse
effects on the developing fetus.
Teratological studies of birth defects originally focused
on miscarriage, fetal death or pregnancy loss, birth defects
and low birth weight. Teratogens were often mutagenic
and caused changes in the DNA sequence, while others
caused general toxicity leading to cell death. Higher doses
w e r eu s u a l l ya s s o c i a t e dw i t hm o r es e v e r ee f f e c t s .I nl a b o r a -
tory studies, the animals were usually killed at birth to allow
assessment of possible birth defects, so that no follow-up
was available to determine any possible impact as to disease
or dysfunction later in life. Later on this practice was
deemed lacking, when evidence surfaced that certain
cancers may originate prenatally, nervous system functions
may be affected by nutrients and toxicants during early de-
velopment, and reproductive development can be harmed
by drugs and toxicants causing endocrine disruption.
Further environmental chemical studies showed that
exposures during development at low doses did not
cause any teratogenic endpoints, although dysfunctions
and diseases showed up later in life. In addition, the che-
micals affected tissue and organ functions only when the
exposure covered critical windows of development. This
observation is consistent with emergent concepts in de-
velopmental physiology. As tissue development is con-
trolled by epigenetic processes, which, in turn, are
influenced by hormones and growth factors with which
environmental chemicals such as EDCs can interfere. In
some tissues and organs, such as the brain, lungs and
immune system, developmental vulnerability continues
through the neonatal period and perhaps into puberty,
thereby extending the period of increased vulnerability
to adverse effects from environmental chemicals. The
original concept of a fetal basis of adult disease was
therefore changed to that of developmental origins of
adult disease, more recently modified to Developmental
Origins of Health and Disease (DOHaD), as adverse
effects may already emerge in childhood and adoles-
cence and health-disease are part of a continuous
spectrum of outcomes in response to risk factors
(Figure 1).
While EDCs initially referred to substances interfering
with reproductive hormones, the term now extends to
compounds that may affect any endogenous hormones
that carry signals from one cell to another, and there are
now about 900 chemicals characterized as EDCs. Such
compounds can alter the effects of the endogenous hor-
mones by acting as receptor agonists or antagonists (or
both, when acting as modulators), thereby resulting in
abnormal hormonal signalling and leading to altered
hormone action. EDCs can also act by affecting hor-
mone concentrations indirectly through signalling
Figure 1 Periods of vulnerability to environmental influences. The most critical period is the perinatal period, during which epigenetic
plasticity is high and can be influenced by a variety of environmental cues, including chemicals, nutrition, infection, etc.). Later in life, growth and
the hormonally active puberty period is also a vulnerability period. In adults it is believed that elder persons are more vulnerable to a variety of
insults.
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ation. Binding of EDCs to hormone receptors results in
tissue-specific, hormone-like effects that may occur at
low doses with dose–response relationships that may be
non-monotonic (e.g., U-shaped or other non-linear)
where the effects at low doses can be more harmful than
at higher doses. For this reason, the effects of low EDC
doses cannot be predicted by extrapolation from high
dose testing results. Such non-monotonic dose–response
curves are well known for many normal physiologic
mechanisms that may include activation of different
pathways at different dose levels and down-regulation of
receptors at high hormone or EDC concentrations.
Biomonitoring studies have shown that humans are
exposed to hundreds of environmental chemicals, many of
which are EDCs. Some examples of EDCs known to alter
disease susceptibility as a result of developmental exposures
in animal models include bisphenol A (from polycarbonate
plastics), phthalates (a softener in plastics), some organo-
phosphate and organochlorine pesticides, nicotine (tobacco
smoking), air pollution, perfluorooctane compounds (stain
and water repellents), and polybrominated diphenyl ethers
(flame retardants) – all chemicals that are found in detect-
able concentrations in blood or urine samples from most
people. As with nutrient effects during development, sev-
eral EDC effects appear to affect specific genes due to
alterations in epigenetic marks. Importantly, changes in
gene expression resulting from EDC exposures during de-
velopment may not be detectable at birth, and some will
only show up later in life. Thus, changes in epigenetic
marks may be useful biomarkers of exposures and potential
disease risk later in life (Figure 2).
Developmental nutrient and toxicant exposures:
Different sides of the same coin
The concept of adult disease having a fetal basis started
with a focus on severe malnutrition during pregnancy in
humans and the susceptibility during adulthood to type
2 diabetes, high blood pressure, and cardiovascular dis-
ease, indicated by a range of early studies, and later
expanded by David Barker and colleagues. Concurrently
with those studies, the adverse health effects of diethyl-
stilboestrol (DES), an estrogenic drug given to pregnant
women to protect pregnancy loss, became apparent in
the offspring of both sexes, thus indicating that maternal
exposures had consequences that affect the health of
their children. Howard Bern coined the term “the fragile
fetus” to indicate fetal vulnerability to endocrine disrupt-
ing chemicals. This was followed by the experimental
demonstration that developmental exposure to environ-
mental chemicals in laboratory animals could lead to
increased susceptibility to disease and dysfunction later
in life. While these two fields of science started inde-
pendently, it is now clear that both are reflections of the
life-course implications of the developmental environ-
ment. Both nutritional imbalance and environmental
chemical exposure, during sensitive windows of develop-
ment, act when tissues are forming, to affect the pheno-
type, thereby impacting on organ functions and disease
susceptibility later in life. So while the fetus may not
only be ‘fragile’, it is plastic and is able to respond adap-
tively to a wide range of challenges and stimuli during
development. Nonetheless this plasticity can set the
scene for enhanced risk of disease later in life.
Both scientific areas are presently supported by exten-
sive laboratory animal and human studies. Predisposition
to many diseases has been shown to result from, or at
least to correlate with, early changes in nutrition or
chemical exposures. The two related disciplines are now
starting to be integrated both in terms of basic and clin-
ical science, and in terms of their public health implica-
tions, as nutrients and environmental chemicals can act
on the same developmental systems over the same time
frames and via similar mechanisms. In some cases, one
Figure 2 Common mechanisms of nutritional disturbance and environmental chemicals. Both nutritional unbalance and exposure to
environmental chemicals can alter hormonal regulation, metabolic pathways, cellular plasticity and a variety of stress signals such oxidative and
endoplasmic reticulum stress. These influence epigenetic factors such as DNA methylation, histone post translational regulation and noncoding
RNA expression. However, these epigenetic effects in turn alter cellular and physiological pathways which may exacerbate their effects, ultimately
leading to long term effects and children or adult diseases.
Barouki et al. Environmental Health 2012, 11:42 Page 5 of 9
http://www.ehjournal.net/content/11/1/42factor may compensate for the effects of another, or the
two may act synergistically to generate a stronger im-
pact. The following features are common to both fields.
 Both nutritional imbalance and environmental
chemicals act during specific windows of sensitivity
and thus show time-, sex-, and tissue-specific effects.
The windows of sensitivity are known only in
general terms, with most research focused on the in
utero and early childhood time periods. The effects
on disease risk are likely to be due to multiple
impacts by nutritional challenges and chemical
exposures accumulated from embryonic
development throughout the life-course. These may
include early childhood, puberty, pregnancy,
menopause and aging (Figure 1).
 While the adverse effects of nutritional imbalance
during development can result in diseases and
dysfunctions later in life, some effects are mediated
by adaptive changes that protect the fetus and child,
but are to the long-term detriment of specific tissue
and organ function, thereby resulting in increased
susceptibility to disease, depending on the
differences between neonatal and adult
environments. Similarly, exposure to environmental
chemicals during development can cause abnormal
gene regulation (e.g., via epigenetic mechanisms)
which may persist and may become apparent later
in life as increased risk of dysfunctions or diseases
(Figure 2). Thus, developmental disruption can
result from multiple impacts by nutritional
imbalance and chemical exposures, accumulated
from embryonic development throughout the life-
course.
 Neither nutritional imbalance nor chemical
exposures need to affect birth weight to generate a
longer-term effect on disease risk. Indeed, there is a
continuum of risk even among those within the
normal range of nutrition (and birth weight) and
with very low doses of environmental chemicals. For
chemical exposures, the effects are most often not
accompanied by a clear change in birth weight.
Thus, new biomarkers, for example, epigenetic
parameters, at birth are needed to assess the
potential for increased disease risk.
 The changes that occur during development due to
nutritional imbalance or environmental chemicals
are often functional in nature, and include
alterations in gene expression, protein
concentrations, cell metabolism and differentiation,
and in cell numbers or location, thus affecting
interactions between cell types and the
establishment of cell lineages. These changes can
lead to subtle morphological changes detected only
during detailed histologic examination and/or
changes in the functional characteristics of tissues,
organs or systems. However, the effects of nutrient
imbalance or chemical exposure need not
necessarily be functional at birth: epigenetic changes
in particular can produce permanent effects on the
promoter regions of specific genes, which will not
become apparent until the appropriate stimuli for
expression, e.g. levels of transcription factors, are
present. This emphasizes again the need for effective
biomarkers, especially epigenetic marks, which can
be measured at birth and which not only indicate
responses to prenatal challenges, but also potential
later responses to risk factors for disease.
 Functional changes result in changed susceptibility
to non-communicable diseases that will likely show
up later in life, with a latency that may vary from
months to years or even decades. The disease or
functional outcome will depend on the stressor, its
concentration and timing. Again, the latency before
the appearance of health impacts necessitates the
development of biomarkers of exposure and the
future risk of ill health that can be measured early in
life.
 A combination of developmental stressors, whether
nutritional or toxic, could cause effects jointly with
similar or other exposures at different times to
trigger or exacerbate adverse effects. While such
combinations may result in additive effects on
similar pathways, cells and tissues, the details vary.
The adverse effects resulting from such stresses can
become apparent as an increased incidence of a
disease or dysfunction, an earlier onset or an
increased severity of the trait. However, the
possibility exists that some interactions between
nutrients and toxicants may lead to reduced disease
risk.
 The effect of either nutritional imbalance or
environmental chemical exposures, depending on
the dose and timing of exposures, can be
transmitted via the germ line to subsequent
generations, thus resulting in transgenerational
inheritance of increased disease risks.
 The major mechanism, as currently understood,
involves epigenetic processes, i.e., altered DNA
methylation, chromatin remodelling and small non-
coding RNAs. The overall result is differential
modulation of epigenetic systems that control gene
expression that persists through mitosis.
 The effects of these stressors can also depend on
genetic background, e.g. genetic polymorphisms. The
effects may be sex-specific and may include changes
in normal sexual dimorphism.
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associated with nutritional and/or environmental
chemical exposures
Developmental processes affect the risk of a wide range
of important non-communicable diseases and can partly
explain the increased prevalence of important diseases
over recent decades. Diseases that have serious implica-
tions for public health include heart disease, obesity and
type 2 diabetes, certain cancer types, and dysfunction of
the reproductive, neurocognitive and immune systems,
all of which may have a substantial economic and soci-
etal impact.
One important example is obesity that has globally
increased in prevalence. Feeding behaviour, satiety, en-
ergy metabolism, and glucose/insulin sensitivity are
examples of a complex interacting control system that
involves the brain, adipose tissue, the gastrointestinal
tract, muscle, liver, and the pancreas, all of which are
connected by neurohumoral processes, and for which
the integrated control is established in part during early
development.
Unbalanced nutrition in utero, associated with either
under- and over-nutrition, can result in increased rates
of obesity later in life. A high maternal pre-pregnancy
BMI has been linked to increased gestational weight
gain, with increased birth weight and fat mass at birth.
Maternal gestational diabetes is also associated with
increased birth weight as well as childhood risks of over-
weight and obesity and, later, of diabetes. Interestingly,
paternal nutrition has also been linked to adverse health
outcomes in offspring in animal models, e.g., paternal
obesity can lead to disrupted insulin secretion and glu-
cose tolerance in offspring. Furthermore, the develop-
mental disruption can be subtle: maternal nutritional
status can affect the offspring epigenetic states and body
composition development independently of birth weight;
first-born children are more likely to develop obesity
and hypertension as adults in part because of greater
maternal constraint in first pregnancies slightly reducing
fetal growth and thus leading to greater potential
mismatch.
Exposure to environmental chemicals has also been
shown to result in increased risk of obesity later in life.
These chemicals are referred to as obesogens. There are
now about 20 chemicals and chemical classes that are
known to lead to increased risk of weight gain later in
life after developmental exposure and many of these
same chemicals can also increase insulin resistance lead-
ing to type 2 diabetes, either concurrently with the obes-
ity or independent of weight gain (examples include
phthalates, bisphenol A, tributyltins, and several
pesticides).
Other data indicate that developmental exposures to
environmental chemicals can interact with unbalanced
nutrition leading to aspects of metabolic syndrome later
in life, indicating that both nutrient and chemical expo-
sures can affect epigenetic processes controlling weight
gain, metabolism and glucose tolerance. Indeed the “per-
fect storm” for obesity could be an interaction between
unbalanced nutrition and environmental chemical expo-
sures during development altering the set-point for
weight gain and metabolism via effects on adipose tissue
deposition, pancreas, muscle, gastrointestinal tract, liver
and brain functions. This altered metabolism could be
continually worsened by mismatched environmental
exposures throughout life along with high fat and sugar
diets as well as insufficient exercise.
Development of the human reproductive system
begins toward the end of the first trimester; studies have
shown its sensitivity to environmental chemicals, espe-
cially EDCs. A variety of dysfunctions and diseases, such
as cryptorchidism, low semen quality, subfecundity,
polycystic ovarian syndrome, testicular cancer, and uter-
ine fibromyoma, have been linked to developmental
exposures to EDCs. Unbalanced nutrition and growth
during development can also lead to changes in repro-
ductive function, e.g., the timing of puberty and
fecundity.
Brain development involves complex developmental
stages that must happen at a particular time and se-
quence. Disruption of a developmental process can lead
to permanent damage that may be reflected in cognitive
deficits, emotional or behavioural change. These changes
may have important consequences in terms of lifetime
income, delinquency risks or later development of de-
generative nervous system disease. The mechanisms of
induction of such adverse neurobehavioral outcomes are
unclear and may involve neuron or progenitor cell tox-
icity, endocrine disruption, and other mechanisms
brought about either by nutritional stressors or toxicant
exposures. Epigenetic mechanisms relating developmen-
tal stress, nutrition and/or environmental chemicals, to
behaviour and neuroendocrine function have been impli-
cated in both animal and human studies.
The immune system undergoes important maturation
during early postnatal development. As originally
reflected in the so-called ‘hygiene hypothesis’, the recog-
nition of foreign antigens after parturition allows proper
detection of and protection against invading micro-
organisms and against cells with an abnormal pheno-
type. If this developmental exposure does not happen
optimally, adverse consequences may include allergy,
autoimmune disease, inflammation and cancer. Again,
the importance of developmental exposures has been
documented, but not the specific role of nutritional im-
balance or individual environmental chemicals, or their
molecular mechanisms.
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exposures to nutrients and environmental chemicals
may have profound effects on organ functions and dis-
ease risks in later life. The risk factors also include
tobacco smoke, drugs, and psychosocial stress. The over-
all impact of these factors, along with nutrients and en-
vironmental chemicals on the incidence of dysfunctions
and non-communicable diseases, is likely to be
substantial.
Data gaps and challenges
The emerging scientific understanding of the long-term
effects of developmental exposures adds a new dimen-
sion to the importance of preventing the negative effects
of environmental chemicals and nutritional imbalance.
This new research paradigm is challenging as it requires
nutritionists, toxicologists, endocrinologists, develop-
mental biologists, clinicians, and epidemiologists to look
for causative factors in the past, as far back as each sub-
ject’s intrauterine life or even into the life of their par-
ents or grandparents. It also demands that life science
researchers using laboratory animals and other models
consider early developmental stages as particularly vul-
nerable to external factors at relatively subtle levels and
with effects which may only become manifest after peri-
ods of latency. The new insights also require prospective
studies to define early-life exposures to chemicals and
nutrients and provide a new emphasis on multi-
generation studies.
To define in detail the role of nutrition and environ-
mental chemical exposure during development in the
etiology of disease will require team efforts in collabora-
tive science. No one discipline alone can explore all the
relevant aspects of disease etiology and pathogenesis
from developmental biology to clinical diagnosis. A
greater focus on mechanisms of the induction of disease
risk is needed with an emphasis on early development.
Since human development is malleable because of de-
velopmental plasticity, the simple presence of epigenetic
change is insufficient to predict disease. Thus, it is crit-
ical to identify those epigenetic changes that are most
predictive of a later phenotype so that they can be used
as relevant markers for disease prevention. As all human
development involves a plastic element, the mere pres-
ence of epigenetic variation may not predict a significant
effect on health in later life. Thus, a crucial research
challenge is to identify the epigenetic modifications that
are predictive of long-term adverse effects.
It is also clear that developmental nutritional imbal-
ance or environmental chemical exposures can lead to
more than one disease over the lifespan. Thus, a focus
on one disease or one stressor may significantly under-
estimate the overall risk of these stressors to non-
communicable disease and dysfunctions. Because disease
prevention is the ultimate goal, these insights into dis-
ease pathogenesis will have important implications for
researchers, funding agencies, regulatory agencies, as
well as health care providers.
Public policy implications
In order to control human exposure to causative sub-
stances, primary prevention and environmental interven-
tions are required with a primary focus on early life,
while employing a life-course approach to reduce the
non-communicable disease burden and its associated
impacts at personal, economic and social levels.
We therefore call for a shift toward primary preven-
tion of disease based on the developmental origins of
health and disease paradigm. A rational approach is to
focus prevention measures on the mother-child pair dur-
ing pre-pregnancy, pregnancy and the first few years of
postnatal life. Measures which improve nutrition, and
reduce exposures to environmental chemicals, from all
environmental compartments (air, water, soil) and in
food and consumer products, are likely to improve child
and maternal health significantly over the short term, as
well as reduce disease incidence and the cost of health
care overall, thereby increasing the quality of life
globally.
This focus on prevention in key developmental stages
also necessitates a significant re-orientation of the edu-
cation of healthcare professionals towards the develop-
mental origins of health and disease.
Changes may be required in the way that risks related
to environmental chemicals are assessed. While it is im-
portant to continue to identify those environmental che-
micals that disrupt development leading to birth defects,
there must be an increased effort to develop criteria and
assays that will capture the latent effects on long term
development reflected by the DOHaD paradigm.
Current evidence on the importance of developmental
disruption suggests that developmental testing should be
included in all protocols for safety testing. Several
aspects of developmental toxicity can already be exam-
ined using standardized protocols, and others must be
added to cover the full spectrum of organ functions and
disease endpoints that may be affected. While epigenetic
marks may be important biomarkers both of exposures
and of disease/dysfunction susceptibility, these endpoints
need to be assessed and their usefulness in predicting
risk determined.
If specific evidence is either absent or inconclusive, the
DOHaD perspective suggests that risk assessments will
need to include considerations on potential developmen-
tal disruption and its consequences so that prevention
will not be unreasonably delayed because of scientific
uncertainty.
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We believe that the developmental paradigm has
reached the stage where the data, while not complete,
are sufficiently robust and replicable across species, in-
cluding humans, to require a policy and public health re-
sponse. The current pandemic of non-communicable
diseases and the increased prevalence of important dys-
functions demand an open interrogation of why current
interventions appear insufficient. We now know that dis-
ease risk can be induced very early in the life course and
that it is modifiable by nutrients and environmental
chemical exposures (along with drugs. infections, and
other types of stresses). The developmental disruption
effects associated with nutrients and environmental che-
micals are likely two sides of the same coin. These data
provide clinicians and policy makers with pertinent in-
formation that can be used to develop procedures and
policies which will lead to a reduction of the incidence
of non-communicable disease.
A new approach towards disease prevention is needed,
with a new emphasis on early development. A rational
methodology is to improve nutrition and reduce envir-
onmental chemical exposures pre-pregnancy, during
pregnancy and during the first few years of life. This
change is likely to have a very large impact on reducing
disease incidence and the cost of health care, while at
the same time increasing the quality of life at a global
level.
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